Shanghai Techbank Medical Technology Co., Ltd, a cardiovascular device maker, has reportedly closed its Series A financing round at upwards of RMB 100 million (USD 14.9 million), co – led by Puhua Capital and Hainan Qishen Venture Capital. The proceeds will go towards the establishment of its global medical device innovation platform.
Company Background and Future Plans
Founded in 2016, Techbank is expected to file for marketing approval for its first product with the National Medical Products Administration (NMPA) during the fourth quarter of this year. Its product pipeline includes implant products for stroke prevention in patients with atrial fibrillation, new – generation endovascular navigation systems, new medical solutions for surgical neuromodulation, prorenata (PRN) volume management implant systems for patients with heart failure, and more.-Fineline Info & Tech
